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Edited by Robert BaroukiAbstract Until now, it is known that hypoxia increases the gly-
colytic enzyme expression at the transcriptional level. Here, we
show evidence that hypoxia increases hepatic glucose output
and HIF-1 and ATF-2-mediated transactivation of phosphoenol-
pyruvate carboxykinase (PEPCK), which plays a critical role as
a rate-limiting enzyme in gluconeogenesis, gene in liver. HIF-1
directly bound to the speciﬁc PEPCK promoter region through
its cognate binding element and found as an active complex with
coactivator CBP. Additionally, ATF-2 was also involved to reg-
ulate hypoxia-dependent PEPCK transcription in the transcrip-
tional complex with HIF-1 and CBP. Interestingly, retinoic
acid (RA) signaling induced the recruitment of HIF-1 on the
PEPCK promoter, resulting from the functional interaction of
HIF-1 and ATF-2 with coactivator CBP. Taken together, these
results suggest that hypoxia signaling leads the hepatic glucose
production and release via the increased gene expression of glu-
coneogenic enzymes, possibly playing a role in providing glucose
to other tissues, such as endothelial, brain and muscle cells.
 2005 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Liver is a key organ in the maintenance of systemic glucose
homeostasis in mammals. The liver keeps blood glucose levels
nearly constant under various nutritional conditions and pro-
vides a crucial source of fuel for the function of many organs
and tissues under conditions of food deprivation. Deﬁcient he-
patic glucose output may lead to hypoglycemia and cause mal-
function of key tissues and organs, such as the central nervous
system, resulting in coma or death. On the other hand, ele-
vated hepatic glucose secretion contributes very signiﬁcantly
to hyperglycemia in both type 1 and type 2 diabetes [1]. Glyco-
genolysis and gluconeogenesis are both key components of he-
patic glucose output; suppression of hepatic gluconeogenesis
has been shown to improve overall glycemic control in both
human patients and type 2 diabetes animal models [2,3].*Corresponding author. Fax: +82 51 513 9258.
E-mail address: molecule85@pusan.ac.kr (J. Cheong).
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doi:10.1016/j.febslet.2005.03.097Changes in oxygen concentration in organisms represent a
fundamental physiologic stimulus. In animals, this stimulus
elicits both acute and chronic responses. Intracellular oxygen
concentrations are maintained within a narrow range due to
the risk of oxidative damage from excess oxygen (hyperoxia),
and of metabolic demise from insuﬃcient oxygen (hypoxia).
Whereas acute responses often entail changes in the activity
of preexisting proteins, chronic responses invariably involve
changes in gene expression.
The phosphoenolpyruvate carboxykinase (PEPCK) pro-
moter is a well-deﬁned model for metabolic regulation of
gene expression [4]. PEPCK, which catalyzes a regulatory
step in gluconeogenesis, is expressed primarily in liver, kid-
ney, small intestine, and adipose tissue, where its synthesis
is regulated at the level of transcriptional initiation. In liver,
dysfunctional regulation of the PEPCK promoter is associ-
ated with the pathophysiology of type 2 diabetes [5,6]. The
PEPCK promoter integrates cues arising from diverse signal-
ing pathways. PEPCK mRNA is induced by glucocorticoids,
thyroid hormone, or glucagon [7], whereas insulin results in a
repression of the promoter activities in a dominant manner
[8]. The PEPCK promoter fragment encompassing 460 to
+73 was demonstrated to be suﬃcient for hormonal regula-
tion in liver, and many of the transcription factors that bind
elements in this region have been identiﬁed [9,10]. Proteins
demonstrated to bind and impact regulation of the PEPCK
promoter include CREB, C/EBPa, C/EBPb, ATF-2, NF1,
HNF3, glucocorticoid receptor (GR), thyroid hormone recep-
tor (TR), retinoic acid receptor (RAR), and retinoid X recep-
tor (RXR). The energy balance state can aﬀect signals for the
PEPCK gene regulation through activating CREB, C/EBPa,
and C/EBPb, whereas ATF-2 mediates the stress response
signals [10].
Most of the previous works on hypoxia-related glucose
metabolism has been focused on glycolysis regulation, while
our results showed that the hypoxia-mediated HIF-1 and
ATF-2 transactivation play a critical role in glucose homeosta-
sis through the increased gluconeogenic enzyme expression in
hepatocytes. Here, we deﬁned major cis-acting regulatory ele-
ments involved in the hypoxia-mediated expression of the
PEPCK gene. Additionally, hypoxia and RA stimuli form an
active transcriptional complex of HIF-1 and ATF-2, and
CBP on the PEPCK promoter. These results suggest that
hypoxia induces hepatic glucose output via a transcriptional
regulation.blished by Elsevier B.V. All rights reserved.
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2.1. Hepatocyte preparation
Livers of 15-day-old rats were perfused through the vena cava with a
buﬀer consisting of: 140 mM NaCl, 2.6 mM KCl, 0.28 mM Na2HPO4/
2H2O, 5 mM glucose, and 10 mM HEPES (pH 7.4). The perfusion was
ﬁrst for 5 min with the buﬀer supplemented with 0.1 mM EGTA and
then for 15 min with the buﬀer containing 5 mM CaCl2 and 0.2 mg/
ml collagenase type 2 (Worthington). The isolated hepatocytes were
then washed and suspended in a small volume of DMEM (Gibco)
without glucose and pyruvate and counted.
2.2. Release of neosynthesized glucose
Hepatocytes were incubated for 2 h at 37 C with shaking in DMEM
without glucose, but in the presence of 1 mM pyruvate, 10 mM lactate
and 250 lM 3-isobutyl-1-methylxanthine. They were then pelleted,
lysed in 0.1% SDS in PBS, and the protein content was determined.
The glucose content of the cell lysate and the supernatant were mea-
sured by the glucose oxidase method.
2.3. Plasmids
HIF-1 cDNA was subcloned into pCMX1. pCMX1 was a gift from
Catherine Thompson (Carnegie Institution of Washington) and was
used in coupled transcription–translation reactions. In vitro transla-
tion products were veriﬁed by [35S]Met incorporation and SDS–PAGE
analysis. The reporter plasmids PEPCK-275 and PEPCK-543 were
constructed by PCR ampliﬁcation of rat genomic DNA encompassing
positions 275 or 543 through +73 of the PEPCK promoter. The
CRE1-mutant PEPCK-275 reporter, was prepared by standard muta-
genesis, changing (99) CCGGCCCCTTACGTCAGAGGCG (76)
to CCGGCCCCTTTTTTCAGAGGCG.
2.4. Gel mobility shift analysis
Nuclear extracts were prepared from rat hepatocytes following with
hypoxia treatment as indicated in the ﬁgure legends. Approximately
10 lg of nuclear extract was incubated with a probe. A double-
stranded oligonucleotide encoding the PEPCK promoter sequence
(promoter positions 149 to 128 for HIF-1 binding and 99 to
76 for ATF-2 binding) was used for gel shift analysis: 5 0-
GTTCCAAACCGTGCTGACCATG-3 0 and 5 0-CCGGCCCCTTA-
CGTCAGAGGCG-3 0, respectively. Binding reactions were assembled
without probe and held 5 min on ice followed by 5 min at room tem-
perature. Probe was added with further room temperature incubation
for 30 min. Samples were separated in 4% acrylamide, 0.5· TBE
[0.045 M Tris, 0.045 M boric acid, and 1.0 mM EDTA (pH 8.0)] gels
run at 200 V constant voltage.
2.5. Transient transfection and luciferase assays
HepG2 cells were transfected by the standard calcium phosphate
method. Cells were incubated with DNA precipitates for 16 h, washed,
and maintained in complete medium 48 h prior to harvest. Relative
luciferase and b-galactosidase activities were determined as described
[10]. Basal promoter activity is reported as the activity observed after
transfection of the reporter plus an appropriate amount of empty
expression vector. In all cases, transfection data represent the means
of three independent experiments.Fig. 1. Hypoxia increases glucose output in hepatocytes. Isolated rat
hepatocytes and human hepatoma cell line HepG2 were incubated for
2 h at 37 C in DMEM without glucose but in the presence of 1 mM
pyruvate and 10 mM lactate. The data are the mean ± SEM of four
experiments. Hepatocytes and HepG2 cells were incubated for 3 h in
the normoxia (12% O2) or in the hypoxia condition (2% O2).2.6. Chromatin immunoprecipitation analysis
Cells were lysed for 5 min in L1 buﬀer (50 mM Tris, pH 8.0, 2 mM
EDTA, 0.1% NP-40, and 10% glycerol) supplemented with protease
inhibitors. Nuclei were pelleted at 3000 r.p.m. and resuspended in L2
buﬀer (50 mM Tris, pH 8.0, 0.1% SDS, and 5 mM EDTA). Chromatin
was sheared by sonication, centrifuged and diluted 10 times in dilution
buﬀer (50 mM Tris, pH 8.0, 0.5% NP-40, 0.2 M NaCl, and 0.5 mM
EDTA). Extracts were pre-cleared for 3 h with 60 ll of a 50% suspen-
sion of salmon sperm-saturated protein A–agarose. Immunoprecipita-
tions were carried out overnight at 4 C. Immunocomplexes were
collected with salmon sperm-saturated protein A for 30 min and
washed three times (5 min each) with high-salt buﬀer (20 mM Tris,
pH 8.0, 0.1% SDS, 1% NP-40, 2 mM EDTA, and 0.5 M NaCl) fol-
lowed by three washes in no salt buﬀer (1· TE). Immunocomplexes
were extracted in 1· TE containing 2% SDS, and protein–DNAcross-links were reverted by heating at 65 C overnight. After protein-
ase K digestion, DNA was extracted with phenol–chloroform and pre-
cipitated in ethanol. About one-twentieth of the immunoprecipitated
DNA was used in each PCR. Quantitative duplex PCR assay was per-
formed to analyze the amount of DNA precipitated by speciﬁed anti-
bodies in proportion to input DNA. Two pairs of primers were used:
Forward (5 0-AAGTTTAGTCAATCAAACGTT-30) and Reverse (5 0-
TGCTTGGTAGCTAGCCCTCCT-3 0) for the PEPCK promoter.
The PCR conditions were as follows: 1.25 U of Taq DNA polymerase
(Amersham Biosciences), 100 ng of each primer, 200 lM dNTP, 2.5 ll
of 10· Taq buﬀer and double-distilled water to a ﬁnal volume of 25 ll:
94 C for 180 s; 34 cycles at 94 C for 45 s, 60 C for 60 s and 72 C for
60 s; ﬁnal elongation at 72 C for 10 min.3. Results
3.1. Hypoxia increases glucose output in hepatocytes and HepG2
cells
It is known that hypoxia increases the glucose utilization in
many cell types for providing ATP. However, for the suﬃcient
supply of the entire glucose amount to some cells including
muscle, vascular endothelial and brain cells, it is required for
maintaining whole glucose homeostasis through hepatic glu-
cose production. To examine whether hypoxia regulates the
hepatic glucose output, we measured the glucose release from
rat hepatocytes and human hepatoma cell line HepG2. As
shown in Fig. 1, hypoxia stimuli (2% oxygen concentration) in-
duced the glucose release in both isolated rat hepatocytes and
cultured HepG2 cells with 45% and 48% increase compared to
normoxia condition (12% oxygen concentration), respectively.
Together, these ﬁndings suggested that the hypoxia stimuli
might have an important role in the biology of endogenous
glucose production and release from hepatocytes.3.2. Hypoxia increases transcriptional activation of PEPCK
promoter by HIF-1 activation
To explore the role of hypoxia stimuli in the regulation of
the hepatic glucose production pathway, we determined the ef-
fect of hypoxia in the gene expression of PEPCK, which is a
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studies, it was examined the eﬀect of hypoxia on transactiva-
tion activity of the PEPCK-275 and PEPCK-543 promoters.
A schematic representation of these luciferase reporter con-
structs is shown at the bottom of Fig. 2. Region A contains
the glucocorticoid response unit (GRU) composed of two glu-
cocorticoid regulatory elements, three accessory factor-binding
sites, and a CRE. This region provides several factor-binding
sites for RAR, RXR, GR, TR, C/EBP, and HNF-3. Region
B contains a cAMP regulatory element (CRE1) (99 to
76) and is immediately adjacent to a nuclear factor 1
(NFI)-binding site. As shown in Fig. 2A, the PEPCK pro-
moter activity was increased more than fourfolds in hypoxia
condition (2% oxygen) compared to normoxia one (12% oxy-
gen). Since there was not a signiﬁcant diﬀerence of transactiva-
tion between the two diﬀerent PEPCK promoters, it was
indicated that hypoxia stimuli conﬁned mainly in the
PEPCK-275 promoter region.
In order to elucidate the direct mediator of transcriptional
activation for hypoxia-mediated PEPCK gene expression, we
examined the transactivation function of HIF-1, which is well
known to mediate hypoxia stimuli in other cells. To further
validate the speciﬁcity of HIF-1 signaling in optimal transacti-
vation, we assessed the transient transfection assay by using
plasmids encoding PEPCK-CRE site binding proteins, includ-
ing C/EBPa and CREB. In Fig. 2B, C/EBPa and CREB over-
expression did not mediate the hypoxia-induced PEPCK
promoter-driven transactivation. These results suggest that
the HIF-1 activation was speciﬁcally required for optimal hy-
poxia-mediated gene expression.Fig. 2. Hypoxia increases transcriptional activation of PEPCK promoter
HepG2 was transfected with 20 ng of reporter plasmid, PEPCK-275-luc/PEP
Transfection results were normalized to b-galactosidase activity, and represe
indicated relative to reporter alone. A schematic representation of the two
transfected with the indicated expression plasmids with reporter construct an
into HepG2 cells along with 50 ng of the indicated expression plasmid, ei
transfection, cells were harvested for luciferase activities. All the transfection
results represented the average of four independent experiments, with fold in3.3. HIF-1 directly binds to PEPCK promoter site and forms an
active complex with CBP on the promoter
HIF-1 activates gene transcription through binding to a con-
sensus DNA element consisting of the sequence TACGTGCT
[11,12]. The prototype of hypoxia-inducible genes is the eryth-
ropoietin (EPO) gene. The oxygen sensitivity is located in an
element 3 0 to the poly-A-addition site of the gene [13–15]. An
8-bp sequence, TACGTGCT, was 1 found to bind a nuclear
factor named HIF-1 [16], present in many EPO- and non-
EPO-producing cell types only under hypoxic conditions
[17,18]. Also the genes of the glycolytic enzymes lactate dehy-
drogenase A, phosphoglycerate kinase 1 and aldolase A were
shown to contain a functional HRE [19,20]. We identiﬁed that
the gluconeogenic PEPCK gene does not possess a complete
8-bp HRE in its 5 0-ﬂanking region, but only a 6-out-of-8-bp
element, CGTGCT, at positions 129/124.
We used electromobility shift assay (EMSA) to examine
whether the putative HIF-1 responsive element (HRE) found
in the PEPCK promoter (from 129 to 124) binds to HIF-
1 protein in rat hepatocyte-derived nuclear extracts. As shown
in Fig. 3A, radiolabeled oligoduplexes corresponding to the
tentative HRE sites in the PEPCK promoter produced speciﬁc
DNA–protein complexes with HIF-1. The binding is competed
for by excess unlabeled consensus HRE oligoduplex (Fig. 3A).
Moreover, addition of a HIF-1 antibody to the incubation
mixture caused a supershift and a decrease in DNA–protein
complex intensity, indicating the presence of HIF-1 in the pro-
tein–DNA complex (ﬁlled arrows, Fig. 3A). The integrity of
the nuclear proteins was assessed by Coomassie blue staining
of SDS–PAGE gels (data not shown).through HIF-1-mediated transactivation. (A) The hepatoma cell line
CK-543-luc with normoxia (12% O2) and hypoxia (2% O2) conditions.
nt the average of three independent experiments, with fold induction
luciferase reporter constructs is shown below. (B) HepG2 cells were
d assayed for reporter activity. 20 ng of reporter vector was transfected
ther in the absence or presence of the hypoxia condition. 48 h after
results were normalized to b-galactosidase activity, and the presented
duction over the level observed with the reporter alone.
Fig. 3. HIF-1 directly binds to PEPCK promoter site with coactivator CBP. (A) A double-stranded oligonucleotide probe containing the HRE site
(from 149 to 128) of the PEPCK promoter was used in electrophoretic mobility shift analysis. Rat hepatocytes were incubated in the normoxia
and hypoxia conditions, were harvested and prepared with a nuclear extract. Each 10 lg of the nuclear extracts was added in a binding reaction.
Cold-HRE DNA fragment (50· concentration) was added as a competitor of 32P-labeled HRE binding. (B) ChIP analysis of factor occupancy on the
chromosomal PEPCK promoters. Following formaldehyde cross-linking, soluble chromatin was prepared. After IP with antibodies against the
indicated proteins (c-Myc, HIF-1, and CBP), precipitated DNAs were used in PCR analysis. Input shows the starting chromatin extracts. (C)
Expression vector for HIF-1 was transfected into HepG2 cells along with reporter construct PEPCK-275 or PEPCK-275(HREm). The presented
results represented the average of three independent experiments, with fold induction over the level observed with the reporter alone.
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expression through mediating the several enhancer-binding
proteins and the basal transcriptional machinery. To examine
the recruitment of CBP in PEPCK promoter by hypoxia sig-
naling with HIF-1 binding to the promoter, it was addressed
whether these factors interact and are assembled on promoters
in cells by chromatin immunoprecipitation (ChIP) assay with
endogenous PEPCK promoters as well as endogenous tran-
scription factor proteins, HIF-1 and CBP. After hypoxia treat-
ment, cells were lysed and solubilized chromatin was
immunoprecipitated, initially with antibodies against c-Myc,
HIF-1 or ASC-2, and recovered DNAs were ampliﬁed by
PCR using promoter-speciﬁc primers. It is clear from the data
in Fig. 3B that CBP recruitment to the HIF-1-recognized pro-
moter was conﬁrmed in cells, but not by c-Myc. Collectively,
these ﬁndings support the notion that hypoxia signaling con-
trols the recruitment of essential components of the transcrip-
tional activation machinery and consequently the eﬃciency of
HIF-1-dependent transcriptional activation of PEPCK, fur-
ther inducing the endogenous hepatic glucose production.
To determine whether the tentative HRE sequence was
responsible for hypoxia-induced transactivation of the PEPCK
promoter, a mutant PEPCK-HRE reporter was constructed by
site-directed mutagenesis. The mutant PEPCK-HRE promoter
was not responsive to hypoxia condition and HIF-1 expression(Fig. 3C). However, transient transfection (Fig. 3C) shows that
hypoxia activated the PEPCK-HRE promoter essentially
equivalently to activation of the PEPCK 275 promoter re-
porter as shown in Fig. 2B. These results indicate that hypoxia
can stimulate PEPCK gene transcription through the direct
protein binding to HRE site of PEPCK promoter.3.4. ATF-2 is also required for hypoxia-mediated PEPCK gene
transactivation
It is noteworthy that the mutant promoter construct
(PEPCK-275(HREm)) at theHRE site did not completely abol-
ish the hypoxia-mediated transactivation of PEPCK-275 pro-
moter expression (Fig. 3C). This result indicates that another
factor(s) should be involved in regulating the induced PEPCK
gene expression by hypoxia stimuli through the transcriptional
regulation of PEPCK-275 promoter. Concomitant with this
ﬁnding, Seko et al. [21] showed that hypoxia activates ATF-2
function through induction of phosphorylation. Based on these
results, it was addressed whether ATF-2 is responsive for medi-
ating another hypoxia-induced PEPCK gene expression in
addition to HIF-1. Transient transfection shows that hypoxia
activated the PEPCK CRE1 promoter, which was known to
respond to ATF-2 [10], essentially equivalently to activation
of the PEPCK 275 reporter (Fig. 4A). Overexpression of
Fig. 4. ATF-2 is also required for hypoxia-mediated PEPCK gene transactivation. (A) HepG2 cells were transfected with the indicated expression
plasmids and assayed for reporter activity with the PEPCK-CRE reporter construct. 20 ng of reporter vector was transfected into HepG2 cells along
with 50 ng of the indicated expression plasmid, either in the absence or presence of the hypoxia condition. 48 h after transfection, cells were harvested
for luciferase activities. All the transfection results were normalized to b-galactosidase activity, and the presented results represented the average of
four independent experiments, with fold induction over the level observed with the reporter alone. (B) Expression vector for HIF-1 was transfected
into HepG2 cells along with reporter construct PEPCK-275 or PEPCK-275m which is mutated in CRE1 site. The presented results represented the
average of three independent experiments, with fold induction over the level observed with the reporter alone. (C) A double-stranded oligonucleotide
probe containing the CRE site (from 99 to 76) of the PEPCK promoter was used in electrophoretic mobility shift analysis. Rat hepatocytes were
incubated in the normoxia and hypoxia conditions, were harvested and prepared with a nuclear extract. Each 10 lg of the nuclear extracts was added
in a binding reaction.
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tion, but the N-terminal domain (ATF-2N), having a role as
a dominant negative mutant, of ATF-2 inhibited hypoxia-
mediated PEPCK gene transactivation.
To further conﬁrm whether the PEPCK CRE1 sequence was
responsible for hypoxia-induced transactivation of the PEPCK-
275 reporter, a mutant PEPCK-275 reporter was constructed by
changing the CRE1 sequence (see Section 2). As predicted,
hypoxia stimuli increased the transactivation of wild type
PEPCK-275 promoter dependent on ATF-2 expression, but
not the CRE1-mutant PEPCK 275 promoter (mut-275) (Fig.
4B). The incomplete inhibition of the mut-275 transactivation
possibly resulted from the HIF-1-mediated activation. These
results indicate that hypoxia can stimulate PEPCK gene tran-
scription through the CRE1 site in addition to the HRE one.
The results shown in Fig. 4A suggest that the DNA-binding
domain of ATF-2 would be more exposed following hypoxia
stimuli, possibly leading to more eﬃcient binding to its cognate
DNA element. To analyze whether increased DNA binding
activity of ATF-2 may be involved in the hypoxia-dependent
stimulation of the PEPCK promoter activity, EMSA analysis
was addressed. Nuclear extracts were prepared from control
cells or hypoxia exposed cells. 10 lg of nuclear extracts of each
cells, as indicated, was incubated with a 32P-labeled probe
spanning the PEPCK CRE1 promoter region between 99
and 76 in the absence or presence of antibodies againstATF-2 or CREB. As shown in Fig. 4C, hypoxia stimuli led
to increased DNA binding activity by ATF-2. As would be
predicted, ATF-2 binding was inhibited by the anti-ATF-2
antibody treatment, but not by the anti-CREB, which is able
to bind PEPCK-CRE1 site also, antibody. This result is consis-
tent with induced DNA binding and transactivation activities
for ATF-2 upon hypoxia condition (Fig. 4).3.5. Hypoxia and RA signaling lead to form the transcriptional
complex of HIF-1, ATF-2 and CBP on PEPCK promoter
Retinoic acid (RA) signaling was known to activate ATF-2
followed by increase of protein interaction with other transcrip-
tional regulators. To further conﬁrm that ATF-2 induces a
functional transcriptional protein complex with CBP and
HIF-1 at the PEPCK gene promoter site upon RA and hypoxia
signaling, it was addressed whether these factors interact and
are assembled on promoters in cells by using ChIP assays. After
providing RA and hypoxia stimuli, cells were lysed and solubi-
lized chromatin was immunoprecipitated, initially with anti-
bodies against c-Myc, ATF-2, HIF-1 or CBP, and recovered
DNAs were ampliﬁed by PCR using PEPCK promoter-speciﬁc
primers. It is clear from the data in Fig. 5A that we could detect
binding of ATF-2, HIF-1, and CBP to the PEPCK promoter,
whereas c-Myc antibody immunoprecipitations did not pro-
duce any signal. Collectively, these ﬁndings support the notion
Fig. 5. Hypoxia and RA induce the transcription active complex of HIF-1, ATF-2, and CBP. (A) ChIP analysis of factor occupancy on PEPCK
promoters. Following formaldehyde cross-linking, soluble chromatin was prepared. After IP with antibodies against the indicated proteins (c-Myc,
HIF-1, ATF-2, and CBP), precipitated DNAs were used in PCR analysis. Input shows the starting chromatin extracts. (B) The hepatoma cell line
HepG2 was transfected with 20 ng of reporter plasmid, PEPCK-275-luc and the indicated plasmids in the absence or presence of hypoxia condition.
Transfection results were normalized to b-galactosidase activity, and represent the average of three independent experiments, with fold induction
indicated relative to reporter alone.
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tively control the recruitment of essential components of the
transcriptional activation machinery and consequently the eﬃ-
ciency of speciﬁc transcriptional activation of PEPCK, which
subsequently coordinate the glucose homeostasis.
To further verify the cooperative transactivation of HIF-1
and ATF-2 with coactivator CBP in the hypoxia condition,
we assessed the PEPCK promoter-dependent transactivation
by the transient transfection with the overexpression of HIF-
1 and ATF-2 in the absence or presence of hypoxia condition
with CBP expression. As shown in Fig. 5B, ATF-2 expression
contributed synergistically the hypoxia-mediated HIF-1-trans-
activation by CBP. This result indicates that hypoxia signaling
activates HIF-1 binding on the PEPCK promoter at its cog-
nate site and induces the CBP recruitment at HIF-1–PEPCK
promoter complex, subsequently the participation of ATF-2
in this enhanceosome composed of HIF-1 and CBP. This
can further increase the hypoxia-mediated transactivation for
PEPCK gene expression.4. Discussion
Glucose output is an essential component of glucose homeo-
stasis and its abnormal regulation is a key pathogenic event in
diabetes mellitus. The present results describe a novel mecha-
nism operating in the last step of glucose production and re-
lease in the hypoxia condition in liver. As hepatic glucose
homeostasis is tightly regulated by hormones, in particular
glucagons and insulin, it will also be important to determine
whether this mechanism is under hormone control. Similarly,
the regulation of gluconeogenic ﬂux, which varies under diﬀer-
ent metabolic conditions, also depends on a variety of diﬀerent
tissue–tissue interactions. Although the liver, kidney, and
intestine all contain the enzymatic machinery necessary to
make glucose, changes in the hormonal milieu have a signiﬁ-
cant impact on where glucose is made, as well as the substrates
that are used as precursors. The metabolic eﬀects of altering
the amount of PEPCK in mice have also been intensely inves-
tigated [22–24]. For glucose homeostasis in whole body, liverneeds to provide glucose to other tissue including brain, mus-
cle, and blood cells.
The mechanisms by which hypoxia leads to these divergent
vasomotor responses is unclear, although it has been fre-
quently proposed that changes in cellular energy state may
be a key factor. However, it is only recently that advances in
technology have allowed correlation of hypoxia, energy state
and function. It is generally thought that oxidative phosphor-
ylation should be maintained even at very low mitochondrial
oxygen tensions because of the high oxygen aﬃnity of respira-
tory chain enzymes. Nevertheless, cellular metabolism during
hypoxia is frequently associated with a dramatic increase in
glycolysis and glucose utilization [25]. There is convincing evi-
dence that cellular energy production and utilization is com-
partmentalized in smooth muscle. Membrane-bound
glycolytic enzymes determine that glycolysis is primarily lo-
cated close to the cell membrane, and ATP from this source
has been reported to preferentially modulate ion channels
and membrane-associated transduction mechanisms during
hypoxia. Thus an inclination towards glycolytic production
of ATP during hypoxia could have selective eﬀects on diﬀerent
systems within the cell. It should be noted that even though the
terminal cytochrome oxidase of the mitochondrial electron
transport chain has a very high sensitivity to oxygen, there is
evidence that even moderate hypoxia can alter mitochondrial
function, reactive oxygen species production and cellular redox
potential [26]. These changes may act as signals for activation
of several mechanisms, including hypoxia-induced transcrip-
tion factors such as HIF-1, and hence upregulation of glyco-
lytic enzymes, glucose transporters and EPO [2]. The
interactions between cellular energy state, metabolism, redox
potential, ROS production and signal transduction mecha-
nisms are complex.
For the liver, oxygen is essential as an electron acceptor in
energy metabolism. It also regulates metabolic zonation in
the normal liver and, under pathological conditions, is a mod-
ulation of liver disease. It had long been known that in per-
fused livers carbohydrate metabolism is signiﬁcantly modiﬁed
by the oxygen supply. Net glycogen synthesis occurred only
above 4% O2. Net glucose uptake occurred above 2% O2 and
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tate uptake (due to gluconeogenesis) in periportal-like cells in-
creased clearly up to 6% O2 and then more moderately. Bratke
et al. [27] showed that in transient transfection of primary
hepatocytes, a normoxia response element was located in the
PEPCK promoter. In addition to this site, Jun and Fos, which
form AP1, are induced by reduced pO2. In the PEPCK pro-
moter, several putative AP-binding sites are known. Since
PEPCK-CRE is closely located with PEPCK-HRE, it is of
interest whether the activation of PEPCK-CRE binding pro-
teins functionally interacts with HIF-1 transactivation. Here
we show that ATF-2, one of PEPCK-CRE binding proteins,
is responsive for hypoxia-mediated transactivation of PEPCK
gene promoter. Because HIF-1 activity is induced by hypoxia
in all cell types, the interaction of HIF-1 with other proteins
is likely to play a major role in determining its biological activ-
ity. In the future study, it is required for identiﬁcation of phys-
ical and functional interaction of ATF-2 and HIF-2 upon
hypoxia stimuli.
Acknowledgement: This work was supported by the Korea Research
Foundation Grant (KRF-2002-041- C00221).References
[1] Saltiel, A.R. and Kahn, C.R. (2001) Insulin signalling and the
regulation of glucose and lipid metabolism. Nature 414, 799–806.
[2] Nordlie, R.C., Foster, J.D. and Lange, A.J. (1999) Regulation of
glucose production by the liver. Annu. Rev. Nutr. 19, 379–406.
[3] Moller, D.E. (2001) New drug targets for type 2 diabetes and the
metabolic syndrome. Nature 414, 821–827.
[4] Hanson, R.W. and Reshef, L. (1997) Regulation of phospho-
enolpyruvate carboxykinase (GTP) gene expression. Annu. Rev.
Biochem. 66, 581–611.
[5] Valera, A., Pujol, A., Pelegrin, M. and Bosch, F. (1994)
Transgenic mice overexpressing phosphoenolpyruvate carboxyki-
nase develop non-insulin-dependent diabetes mellitus. Proc. Natl.
Acad. Sci. USA 91, 9151–9154.
[6] Loose, D.S., Cameron, D.K., Short, H.P. and Hanson, R.W.
(1985) Thyroid hormone regulates transcription of the gene for
cytosolic phosphoenolpyruvate carboxykinase (GTP) in rat liver.
Biochemistry 24, 4509–4512.
[7] Kioussis, D., Reshef, L., Cohen, H., Tilghman, S.M., Iynedjian,
P.B., Ballard, F.J. and Hanson, R.W. (1978) Alterations in
translatable messenger RNA coding for phosphoenolpyruvate
carboxykinase (GTP) in rat liver cytosol during deinduction.
J. Biol. Chem. 253, 4327–4332.
[8] McGrane, M.M., Yun, J.S., Moorman, A.F., Lamers, W.H.,
Hendrick, G.K., Arafah, B.M., Park, E.A. and Wagner, R.W.
(1990) Metabolic eﬀects of developmental, tissue-, and cell-speciﬁc
expression of a chimeric phosphoenolpyruvate carboxykinase
(GTP)/bovine growth hormone gene in transgenic mice. J. Biol.
Chem. 265, 22371–22379.
[9] Short, M.K., Clouthier, D.E., Schaefer, I.M., Hammer, R.E.,
Magnuson, M.A. and Beale, E.G. (1992) Tissue-speciﬁc, devel-
opmental, hormonal, and dietary regulation of rat phosphoenol-
pyruvate carboxykinase-human growth hormone fusion genes in
transgenic mice. Mol. Cell. Biol. 12, 1007–1020.
[10] Cheong, J., Coligan, J.E. and Shuman, J.D. (1998) Activating
transcription factor-2 regulates phosphoenolpyruvate carboxyki-nase transcription through a stress-inducible mitogen-activated
protein kinase pathway. J. Biol. Chem. 273, 22174–22178.
[11] Semenza, G.L., Nejfelt, M.K., Chi, S.M. and Antonarakis, S.E.
(1991) Hypoxia-inducible nuclear factors bind to an enhancer
element located 30 to the human erythropoietin gene. Proc. Natl.
Acad. Sci. USA 88, 5680–5684.
[12] Beck, I., Ramirez, S., Weinmann, R. and Caro, J. (1991)
Enhancer element at the 30-ﬂanking region controls transcrip-
tional response to hypoxia in the human erythropoietin gene.
J. Biol. Chem. 266, 15563–15566.
[13] Pugh, C.W., Tan, C.C., Jones, R.W. and Ratcliﬀe, P.J. (1991)
Functional analysis of an oxygen-regulated transcriptional
enhancer lying 3 0 to the mouse erythropoietin gene. Proc. Natl.
Acad. Sci. USA 88, 10553–10557.
[14] Bunn, H.F. and Poyton, R.O. (1996) Oxygen sensing and
molecular adaptation to hypoxia. Physiol. Rev. 76, 839–885.
[15] Wenger, R.H. and Gassmann, F. (1997) Oxygen(es) and the
hypoxia-inducible factor-1. Biol. Chem. 378, 609–616.
[16] Semenza, G.L. and Wang, G.L. (1992) A nuclear factor induced
by hypoxia via de novo protein synthesis binds to the human
erythropoietin gene enhancer at a site required for transcriptional
activation. Mol. Cell. Biol. 12, 5447–5454.
[17] Maxwell, P.H., Pugh, C.W. and Ratcliﬀe, P.J. (1993) Inducible
operation of the erythropoietin 30 enhancer in multiple cell lines:
evidence for a widespread oxygensensing mechanism. Proc. Natl.
Acad. Sci. USA 90, 2423–2427.
[18] Wang, G.L. and Semenza, G.L. (1993) General involvement of
hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Proc. Natl. Acad. Sci. USA 90, 4304–4308.
[19] Firth, J.D., Ebert, B.L., Pugh, C.W. and Ratcliﬀe, P.J. (1994)
Oxygen-regulated control elements in the phosphoglycerate
kinase 1 and lactate dehydrogenase A genes: similarities with
the erythropoietin 30 enhancer. Proc. Natl. Acad. Sci. USA 91,
6496–6500.
[20] Semenza, G.L., Roth, P.H., Fang, H.M. and Wang, G.L. (1994)
Transcriptional regulation of genes encoding glycolytic enzymes
by hypoxia-inducible factor 1. J. Biol. Chem. 269, 23757–23763.
[21] Seko, Y., Takahashi, N., Tobe, K., Kadowaki, T. and Yazaki, Y.
(1997) Hypoxia and hypoxia/reoxygenation activate p65PAK, p38
mitogen-activated protein kinase (MAPK), and stress-activated
protein kinase (SAPK) in cultured rat cardiac myocytes. Biochem.
Biophys. Res. Commun. 239, 840–844.
[22] Sun, Y., Liu, S., Ferguson, S.,Wang, L., Klepcyk, P., Yun, J.S. and
Friedman, J.E. (2002) Phosphoenolpyruvate carboxykinase over-
expression selectivelyattenuates insulin signalingandhepatic insulin
sensitivity in transgenic mice. J. Biol. Chem. 277, 23301–23307.
[23] She, P., Shiota, M., Shelton, K.D., Chalkley, R., Postic, C. and
Magnuson, M.A. (2000) Phosphoenolpyruvate carboxykinase is
necessary for the integration of hepatic energy metabolism. Mol.
Cell. Biol. 20, 6508–6517.
[24] Rosella, G., Zajac, J.D., Baker, L., Kaczmarczyk, S.J., Andrik-
opoulos, S., Adams, T.E. and Proietto, J. (1995) Impaired glucose
tolerance and increased weight gain in transgenic rats over-
expressing a non-insulin-responsive phosphoenolpyruvate car-
boxykinase gene. Mol. Endocrinol. 9, 1396–1404.
[25] Cartee, G.D., Dounen, A.G., Ramlai, T., Klip, A. and Holloszy,
J.O. (1991) Stimulation of glucose transport in skeletal muscle by
hypoxia. J. Appl. Physiol. 70, 1593–1600.
[26] Chandel, N.S. and Schumacker, P.T. (2000) Cellular oxygen
sensing by mitochondria: old questions, new insight. J. Appl.
Physiol. 88, 1880–1889.
[27] Bratke, J., Keitzmann, T. and Jungermann, K. (1999) Identiﬁca-
tion of an oxygen-responsive element in the 5 0-ﬂanking sequence
of the rat cytosolic phosphoenolpyruvate carboxykinase-1 gene,
modulating its glucagon-dependent activation. Biochem. J. 339,
563–569.
